Skip to main content

Closed

TENX: Tenax Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-43.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio15.07×

Tenax Therapeutics, Inc.

TENXNASDAQ Capital Market·USD·Closed

Tenax Therapeutics, Inc.

TENXNASDAQ·USD·Closed

$13.70

−9.27%

$13.70

−$1.40 (9.27%)

52W Range

58thpctl

Volume

1.61×avg

Mkt Cap

235.61MUSD

P/E

-9.2TTM

Div Yield

–ann

52W Range

58thpctl

Volume

1.61×avg

Market Cap

235.61MUSD

P/E Ratio

-9.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings